grant

Sex dependent dysregulation of parvalbumin interneurons as a pathway to Autism Spectrum Disorder

Organization FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHLocation MANHASSET, UNITED STATESPosted 23 Sept 2024Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY20250-11 years old21+ years old7S Gamma GlobulinASDAdjuvantAdultAdult HumanAffectAgeAmmon HornAntibodiesApicalApoptosisApoptosis PathwayApoptoticAutismAutistic DisorderBasal Transcription FactorBasal transcription factor genesBehavioralBrainBrain Nervous SystemCCKCUT&RUNCell BodyCell NucleusCellsChildChild YouthChildren (0-21)CholecystokininChromatinCleavage Targets and Release Using NucleaseCleavage Under Targets and Release Using NucleaseConnector NeuronCornu AmmonisCyclic SomatostatinDataDendritesDevelopmentDifferences between sexesDiffers between sexesDisproportionate number of menDisproportionately impacts malesDisproportionately in menDysfunctionEarly Infantile AutismElectrodesEncephalonEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEquilibriumExhibitsExposure toExpression SignatureExternal DomainExtracellular DomainFemaleFunctional disorderGender BiasGene Expression ProfileGene TranscriptionGeneral Transcription Factor GeneGeneral Transcription FactorsGeneticGenetic TranscriptionGestationGrowth Hormone Inhibiting FactorsGrowth Hormone-Inhibiting HormoneHippocampusHu-mABsHumanIgGImmunizationImmunizeImmunoglobulin GImmunohistochemistryImmunohistochemistry Cell/TissueImmunohistochemistry Staining MethodImplantIn Situ Nick-End LabelingInfantile AutismIntercalary NeuronIntercalated NeuronsInterneuron functionInterneuronsInternuncial CellInternuncial NeuronKanner's SyndromeLabelLocationMaternal antibodyMeasuresMedialMediatingMental disordersMental health disordersMiceMice MammalsModelingModern ManMothersMurineMusNerve CellsNerve UnitNervous System DiseasesNervous System DisorderNeural CellNeurocyteNeurologic DisordersNeurological DisordersNeuronsNucleic Acid Regulator RegionsNucleic Acid Regulatory SequencesNucleusPancreozyminParvalbuminsPathway interactionsPatternPhenotypePhysiologicPhysiologic pulsePhysiologicalPhysiopathologyPlayPredispositionPregnancyProgenitor CellsProgrammed Cell DeathProliferatingPropertyProteinsPsychiatric DiseasePsychiatric DisorderPulsePyramidal CellsPyramidal neuronRNA ExpressionReceptor ProteinRegulationRegulator GenesRegulatory RegionsResearchRisk-associated variantRoleSRIHSRIH-14Sex BiasSex DifferencesSexual differencesSingle-Nucleus SequencingSliceSomatostatinSomatostatin-14Somatotropin Release Inhibiting FactorsSomatotropin Release-Inhibiting HormoneSusceptibilitySynapsesSynapticTUNELTechniquesTimeTranscriptionTranscription Factor Proto-OncogeneTranscription factor genesTranscriptional Regulatory ElementsTransposaseUropancreozyminVentricularadulthoodagesautism spectral disorderautism spectrum disorderautistic childrenautistic spectrum disorderbalancebalance functionbehavior phenotypebehavioral phenotypingcalbindin 2calretinincandidate identificationchildren on the autism spectrumchildren with ASDchildren with autismchildren with autism spectrum disordercompare to controlcomparison controldevelopmentaldisease riskdisorder riskdisproportionately affects malesdisproportionately affects mendisproportionately concentrated among mendisproportionately distributed among mendisproportionately higher among mendisproportionately impacts mendisproportionately occurs in menepigenetic regulationepigeneticallyexcitatory neuronexposed in uterofetal exposuregene expression patterngene expression signaturegenetic regulatory elementgenetic trans acting elementgrowth hormone release inhibiting factorhippocampalhippocampal pyramidal neuronhumAbshuman mAbshuman monoclonal antibodieshuman monoclonalsin utero exposureintra-uterine environmental exposureintrauterine environmental exposurekidsmalemale biasmale predominancemen disproportionately diagnosedmen disproportionately experiencemen experience disproportionate ratesmental illnessmigrationmouse modelmurine modelneural cell bodyneurological diseaseneuronalneuronal cell bodynew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapy approachesnew treatment approachnew treatment strategynovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapy approachoffspringpathophysiologypathwaypostnatalpostsynapticpredominantly affecting menprenatal exposureprenatally exposedprogenitorprogenitor cell proliferationprogenitor proliferationpsychiatric illnesspsychological disorderreceptorregulatory generesponserisk allelerisk generisk genotyperisk locirisk locusrisk variantsNuc-Seqsexsex based differencessex-dependent differencessex-related differencessex-specific differencessingle nucleus RNA-sequencingsingle nucleus seqsingle-nucleus RNA-seqsnRNA sequencingsnRNA-seqsocial rolesomastem and progenitor cell proliferationstem cell proliferationstem cellssynapseterminal nick end labelingtrans acting elementtranscription factortranscriptional profiletranscriptional signatureyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY/ ABSTRACT
Altered GABAergic interneurons have been documented following genetic and environmental perturbations in Autism

Spectrum Disorder (ASD) suggesting that GABAergic interneurons might be particularly susceptible and contribute to

ASD pathophysiology. We identified Caspr2, a neuronal protein to be a target of 3 monoclonal IgG derived from

mothers with anti-brain antibodies (Ab) with an ASD child, and found that ~40% of mothers with anti-brain Ab harbor

anti-Caspr2 IgG. Caspr2 expression is localized during development to proliferating progenitor cells of pyramidal

neurons in the ventricular zone and to the medial ganglionic eminence (MGE) where somatostatin and parvalbumin

interneurons (PVI) arise. It is involved in stabilization of dendrites and synapses and is an ASD risk gene. Its brain

expression is similar between females and males throughout gestation. We have demonstrated that exposure in utero

to either human monoclonal anti-Caspr2 IgG or polyclonal anti-Caspr2 IgG results in male offspring with structural

and behavioral alterations. Female offspring show no such alterations. Here we focus on the immunization model in

which female mice are immunized with the extracellular domain of human Caspr2 and harbor endogenous polyclonal

anti-Caspr2 Abs throughout gestation. Male mice exposed in utero to anti-Caspr2 IgG (“Anti-Caspr2”) exhibit a specific

reduction in PVIs but not in number of other hippocampal interneurons such as somatostatin, calretinin and

cholecystokinin in the CA1 region of the hippocampus compared to adjuvant immunized control mice (“Control”). The

reduction in PVIs is evident at postnatal age P21 and is not accompanied by a reduction in total number of GABAergic

cells. The reduction in PVIs in Anti-Caspr2 male mice is not explained by a reduction in PV progenitor cells or altered

migration, as number of proliferating and apoptotic progenitor interneurons in the MGE and the number of migratory

MGE interneurons is similar between Control and Anti-Caspr2 male mice. Given the contribution of PVIs to gamma

oscillations, we implanted multi-electrodes in Anti-Caspr2 male mice, targeted to the striata oriens and pyramidale,

and calculated relative power of the gamma band. Anti-Caspr2 male mice exhibit a significant increase in mid and

high gamma oscillations. Taken together, the model permits a study of the impact of PVIs during development as they

pertain to ASD. Our hypothesis is that in utero exposure to anti-Caspr2 Abs has sex specific epigenetic effects on PVI

maturation, which contribute to network imbalance in male mice.

We therefore propose to study:

1. Whether the reduction in PV expression in the CA1 region of the hippocampus is associated with epigenetic

changes that disrupt the normal transcriptional profile of PVIs in male but not female Anti-Caspr2 mice.

2. When abnormal PVIs network patterns develop in Anti-Caspr2 mice and what are the functional consequence

of disrupting PVI development using ex vivo hippocampal slices.

Grant Number: 5R21MH136489-02
NIH Institute/Center: NIH

Principal Investigator: Lior Brimberg

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →